Diabetes drug could help cancer patients make better recovery, suggests study Dr. Kamal Kant Kohli11 March 2025 6:45 AM ISTA common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of...
Dapagliflozin prevents renal injury by improving mitochondrial function and reducing oxidative stress in diabetes patients: Study Medha Baranwal19 Feb 2025 8:45 AM ISTChina: A recent study published in the Journal of Diabetes and its Complications highlighted dapagliflozin's (DAPA) protective role in counteracting...
Ertugliflozin Lowers Uric Acid and Reduces Gout Risk in Type 2 Diabetes Patients with CVD, VERTIS CV Analysis Medha Baranwal24 Sept 2024 9:00 AM ISTCanada: Recent post hoc analyses from the VERTIS CV trial reveal promising results for ertugliflozin, a medication used to manage type 2 diabetes. The...
SGLT2 inhibitor empagliflozin safe and effective for treating patients who have suffered MI: EMPACT-MI, ESC 2024 Dr. Kamal Kant Kohli3 Sept 2024 10:30 AM ISTThe SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are...
Triple Combination Therapy Effective for Drug-Naive Type 2 Diabetes Patients, shows new Study Medha Baranwal11 July 2024 10:00 AM ISTKorea: A study has demonstrated that initiating treatment with a triple combination therapy (TCT) comprising metformin, dapagliflozin, and saxagliptin...
Semaglutide Shines in Kidney Health Across Diabetes Patients: Study Highlights Consistency and Potential Medha Baranwal5 July 2024 9:15 AM ISTGermany: A recent clinical trial, known as the FLOW trial, has provided significant insights into treating type 2 diabetes and chronic kidney disease...
SGLT2 inhibitors may Safely Reduce Progression of Kidney Disease in Adolescents with Type 1 Diabetes: ADA Dr. Kamal Kant Kohli27 Jun 2024 8:00 AM ISTToday, findings from the ATTEMPT study, showed that a low-dose of SGLT2 inhibitor could safely be given to youth and adolescents with type 1 diabetes...
Empagliflozin fails to reduce HF hospitalizations, deaths after acute MI: EMPACT-MI Medha Baranwal9 April 2024 10:00 AM ISTUSA: Treatment with empagliflozin did not lead to a significantly reduced risk of first hospitalization for heart failure (HF) or death from any cause...
SGLT2i-associated ketoacidosis patients receive significantly lower insulin doses vs those with T1D ketoacidosis: JAMA Medha Baranwal26 March 2024 8:30 AM ISTAustralia: A new retrospective cohort study revealed a clinically relevant reduction in the doses of insulin administered over the first 24 hours of...
Ipragliflozin treatment improves blood sugar control avoiding ketoacidosis in patients with type 1 diabetes Medha Baranwal14 Feb 2024 10:45 AM ISTJapan: Ipragliflozin treatment for type 1 diabetes (T1D) may help improve glycaemic control/variability while avoiding ketoacidosis, according to...
Diabetes medication to lower the risk of kidney stones says study Niveditha Subramani1 Feb 2024 4:09 PM ISTDiabetes when left untreated can increase the acidity of the urine. With high blood glucose levels, the acidity of the blood increases, which in turn...
FDA Approves Empagliflozin for CKD treatment, regardless of diabetes status Dr. Kamal Kant Kohli23 Sept 2023 10:45 AM ISTThe US Food and Drug Administration has approved another SGLT2 Inhibitor Empagliflozin for treatment of CKD regardless of diabetes status.Jardiance®...
